Precision medicine in premature ovarian insufficiency: a focus on the precision therapeutic strategies for mesenchymal stem cells
Abstract Premature ovarian insufficiency (POI) is one of the most common disorders that reduces fertility and the quality of life in young women. And mesenchymal stem cells (MSCs) have gradually been regarded as a promising therapeutic approach for POI for their potential in remodeling impaired ovar...
Saved in:
| Main Authors: | Rou Wang, Fengyuan Liu, Qiuyue Liao, Jiachen Wu, Lingjuan Wang, Kezhen Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Stem Cell Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-025-04512-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Functions and Implications of MicroRNAs in Premature Ovarian Insufficiency
by: Hui Gao, et al.
Published: (2025-02-01) -
Factors influencing premature ovarian insufficiency: a systematic review and meta-analysis
by: Shuling Lin, et al.
Published: (2025-12-01) -
Exosomes derived from hypoxic mesenchymal stem cell ameliorate premature ovarian insufficiency by reducing mitochondrial oxidative stress
by: Shanshan Zhang, et al.
Published: (2025-03-01) -
Ovarian Activation Surgical Techniques for Women with Premature Ovarian Insufficiency or Poor Ovarian Response: A Systematic Review
by: Antonio D'Amato, et al.
Published: (2025-04-01) -
Sustained release of miR-21 carried by mesenchymal stem cell-derived exosomes from GelMA microspheres inhibits ovarian granulosa cell apoptosis in premature ovarian insufficiency
by: Xiaofei Zhang, et al.
Published: (2025-04-01)